Study Design. A comparative study of radiation dose measured in anthropomorphic phantoms. Objectives. The aim of this study was to first report the first organ dose and effective dose measurements in anthropomorphic phantoms using the new EOS imaging micro-dose protocol in full-spine examinations, and to compare these measurements of radiation dose to measurements in the EOS standard-dose protocol and conventional digital radiology (CR). Summary of Background Data. Few studies evaluating organ dose and effective dose for the EOS low-dose scanner exist, and mainly for the standard-dose protocol. To the best of our knowledge, no studies of effective dose based on anthropomorphic phantom measurements exist for the new micro-dose protocol. Methods. Two anthropomorphic phantoms, representing a 5-year-old (pediatric) and a 15-year-old (adolescent). The phantoms were exposed to EOS micro-dose and standard-dose protocols during full-spine imaging. Additionally, CR in scoliosis settings was performed. For all modalities, organ doses were measured and effective doses were calculated using thermoluminescent dosimeters.
A dequate radiological imaging is required for the assessment and treatment of spinal deformity. Patients are frequently exposed to numerous radiographs, during diagnosis and treatment, whether conservative or surgical, and follow-up. The higher the total absorbed radiation dose, the higher is the risk of developing radiation-induced cancer. The atom bomb survivor studies 1 show a direct correlation between the total absorbed radiation dose and the risk of developing cancer. Especially children are at risk, as the stochastic damage caused by ionizing radiation often has a latency period of one or more decades before developing into cancer. 2 A large cohort study 3 showed a 68% increase in mortality, with a standard mortality ratio of 1.68 from breast cancer amongt a cohort of 5573 scoliosis patients followed for >40 years after being diagnosed and exposed to frequent radiographic examinations. Furthermore, a recent study indicated an increased risk of endometrial cancer amongst scoliosis patients as well. 4 To address this challenge, much effort has gone into optimizing radiologic equipment and finding alternatives to keep radiation dose as low as possible to decrease the risk of radiation-induced cancer while maintaining adequate image quality, commonly referred to as the ALARA principle (as low as reasonable achievable). 5 The EOS low-dose imaging system (EOS imaging, Paris, France) has been developed to produce high-quality images at low radiation doses. 6 We have been using the EOS scanner for full-spine examinations at our institution, since the fall of 2014. The EOS scanner uses a bi-planar slotscanning technology, which has been described in detail elsewhere. [7] [8] [9] [10] The original version of the system had a standard low-dose protocol. Lately, a micro-dose protocol with even lower dose imaging has become an option. EOS standard-dose setting has mainly been evaluated with regards to skin entrance dose; 7,9,11 however, only a few studies have evaluated organ dose and full-body absorbed dose (effective dose). [10] [11] [12] The micro-dose protocol has so far mainly been evaluated in terms of image quality, although an up to 45-fold reduction of absorbed radiation dose compared to CR has been stated; 13 a recent study reported effective dose estimates, based on the Monte Carlo dose-simulation program (PCXMC) 14 using a mathematical phantom. The microdose protocol has previously been reported to provide the clinician with images comparable to CR. 13, 15 The dual aim of our study was to report the first-ever organ dose and effective dose measurements in anthropomorphic phantoms using the EOS micro-dose protocol, and to compare our results to measurements in the EOS standard-dose protocol and CR.
MATERIALS AND METHODS

Phantom Exposure
Two clinically validated anthropomorphic CIRS-ATOM phantoms (Computerized Imaging Reference System, Inc. Norfolk, VA), 16 a female adult (representing an adolescent), and a pediatric were used. ATOM dosimetry phantoms have been designed to explore organ dose and effective dose, they consist of tissue equivalent epoxy resins and hold dosimeter locations specific to 21 inner organs.
Each phantom was positioned in the upright position within the EOS scanner ( Figure 1 ). Full spine biplane radiological examinations were performed in two positions: anterior-posterior-lateral (APL) and posterior-anterior-lateral (PAL). Left lateral side of the phantom facing x-ray source in the APL position and right lateral side in PAL. Vertical collimation with a laser positioning system was done in order to ascertain identical scan fields.
The micro-dose protocol shown in Table 1 differs from the standard-dose protocol by featuring increased cobber (Cu) filtration, decreased x-ray tube voltage (kV), and optimized image processing.
As previously described by Damet et al, 10 20 consecutive scans were performed in each position to accumulate sufficient dose for measurements of the absorbed dose. The doses measured for each position were normalized into single examinations, and are listed as such in tables and figures. Measurements were done similarly for full-spine posterioranterior (PA) and anterior-posterior (AP), and subsequently, lateral (LAT) positions in CR (Siemens Ysio Max, Malvern, PA., USA), with CR long cassette wall stand, imaging parameters used are shown in Table 2 . For CR LAT exposures, the right lateral side of the phantoms faced the x-raysource according to in-house scoliosis protocol.
Dosimetry
Thermoluminescent dosimeters (TLD) (MCP-N, Krakow, Poland) were used for dosimetry. MCP-N dosimeters have a threshold of detecting radiation that is 200 times lower than more commonly used TLD-100 dosimeters.
Each TLD was placed within the phantoms at organspecific positions and table-listed depths; eight dosimeters were placed on skin surfaces. All available internal dosimeter locations were used. The total of measuring points was in the range 184 (pediatric phantom) to 298(adolescent phantom). For calibration and dose readings, Rados IR-2000 irradiator and the Rados RE-2000 reader (RadPro International GmbH, Wermelskirchen, Germany) were used. Mean organ doses were measured, and effective doses were calculated as described in previous studies. 10, 17 Effective dose ðEÞ; E ¼ P w T H T represents the full-body stochastic health risk, which is the probability of cancer induction and genetic effects, from any partial radiation of the body. Effective dose is measured in milisieverts (mSv), and according to the International Commission on Radiological Protection(ICRP) publication 103, 5 calculated by summing the equivalent dose of each organ (H T ), which for x-ray radiation is equal to the average absorbed radiation dose for each organ, multiplied by a tissue-specific weighting(W T ) factor.
Statistical Methods
Radiation dose was visualized by log 10 -transforming measurement data to compare standard-dose and micro-dose. Furthermore, this reduced variability of data observed because of the underlying proportionality in mean and variance. We used a negative binominal regression method in order to statistically model data. Data observation was used to identify the expected additive structure in mean for the radiation dose, that is, the only interaction terms were between organs and the position of the phantom relative to the source (APL/PAL). From the statistical model, expected tissue/organ levels were estimated for the two directions (APL/PAL) with an additive term due to different dose protocols. Based on the estimated model parameters and associated standard errors, the ratio of absorbed dose was compared between CR, micro-dose, and standard dose. The estimated absorbed dose was evaluated using the estimated model parameters and tissue factors from predetermined positions. The associated 95% confidence intervals were evaluated using parametric bootstrap similar to the mean estimate. 18 This parametric bootstrap was used to assess how the uncertainty in parameter estimates was manifested in the absorbed dose. Main results have been expressed with 95% confidence intervals. 
RESULTS
Final Inclusions
Adolescent Phantom All 290 internal TLD positions were available for TLD placement, so were eight dosimeters placed on skin surfaces around the phantom. A few dosimeters were lost during dosimetry; one to six of a total of 298 equal to 0.3% to 2% of the dosimeters were used for calculating effective dose.
Pediatric Phantom
A total of 176 of 180 internal TLD positions were available for placement of dosimeters. Four positions lost were because of image quality insert cylinders. An additional eight dosimeters were placed on the surface of the phantoms for skin dose measurements. In most positions and exposure-protocols, a few dosimeters were lost during read-outs, either because they were broken or had fallen out. The number of lost dosimeters ranged from zero to two per exposure position, equal to 0 to 1% of the dosimeters used for calculating effective doses. Dosimeter readings from the three positions representing prostate and testes have not been included in the results; the phantoms represented females. Figure 2 provides an overview of effective doses for both phantoms and exposure positions, including CR.
Effective Doses
Adolescent Phantom
We observed a 17-fold reduction (94%) of absorbed dose in micro-dose settings compared to measured dose absorbed with CR. Effective dose for PAL full spine, bi-planar, radiographic examination with the micro-dose protocol was 29 mSv (27-31); the corresponding dose for CR PA-LAT was 491 mSv (456-531). A six-fold reduction (83%) of effective dose was observed when comparing micro-dose with standard dose protocol. A 2.8-fold (64%) reduction of effective dose reduction was observed when comparing standard dose protocol with our CR system in PA-LAT.
Pediatric Phantom
Effective dose for PAL full spine, bi-planar radiographic examination with the micro-dose protocol was 22 mSv (20-23); the corresponding dose for CR PA-LAT was 114 mSv (104-127); this is equivalent to a five-fold reduction, (81%) of absorbed dose. A seven-fold reduction (86%) of effective dose was observed when comparing micro-dose with standard-dose protocol. However, there was an increase in absorbed dose of 38% when the EOS standard dose settings were compared with our CR system in PA-LAT.
Organ Doses
Figures 3 to 6 demonstrate organ doses with micro-dose and standard-dose protocols for both phantoms, and show PAL/ APL relations. For most organs, doses were lower in PAL than in APL. Effective doses in PAL compared with APL were reduced by an average of 21% (20%-22%) for the phantoms in both standard and micro-dose protocols. The adolescent mean organ dose to the breasts was reduced by 29% in PAL; this reduction was solely on the left breast where dose was reduced from 403 to 73 mSv, a 5.5-fold reduction, whereas the right breast dose was increased from 216 to 287 mSv, a 33% increase in dose.
DISCUSSION
To the best of our knowledge, the present study reports the first, anthropomorphic phantom-based, measurements of effective dose and organ dose using the EOS micro-dose protocol. We showed a significant reduction of absorbed doses using the micro-dose setting compared with a conventional system and to EOS standard-dose settings as summarized in Figure 2 . We confirmed the manufacturer's claim that the micro-dose scan delivers radiation equal to <1 week of natural background radiation; viz. the mean weekly exposure is 46 mSv. 19 This finding corroborates that radiographic fullspine examinations can be performed without exposing the patient to more than very low amounts of ionizing radiation.
By presenting organ dose measurements in a micro-dose protocol and calculating the effective dose, we contribute to the ongoing evaluation of the risk of tissue detriment and death from radiation-induced cancer. With an average world-wide annual effective dose of 2.4 mSv (range1-10) per capita 19 from natural background exposure, a full-spine examination with micro-dose protocol and an effective dose of 22-37 mSv represents a very low dose. Two annual fullspine examinations with micro-dose protocol for 25 consecutive years would yield an accumulated effective dose <2 mSv, which is equivalent to <1 year of natural background exposure. Hence, the EOS micro-dose option offers full-spine imaging at an almost negligent radiation level. A recent study 13 reports a 45-fold dose reduction with the micro-dose protocol compared with CR. This is, in fact, true if one was to compare to the dose delivered in conventional scoliosis full-spine examinations where radiation doses have been reported to reach around 3.5 mSv. 13, 20 As shown by our study, the CR dose with modern equipment used for AP-LAT spine imaging reached 0.545 mSv in the adolescent phantom. Damet et al 10 found a comparable figure of 0.450 mSv for full-spine AP-LAT full-spine. Compared with our CR reference for PA-LAT full-spine doses, the microdose protocol offers a 17-fold reduction, which is still a marked reduction, but not in the means of 45-fold reduction. The radiation doses from modern systems have been much reduced, 3, 21 and it seems that some reference guidelines for full-spine effective doses need to be updated or reconsidered as far as the description of the dose reduction afforded by new systems is concerned.
Interestingly, in the pediatric phantom, our standarddose protocol showed no dose reduction compared with our reference CR. The child CR measurements were repeated and yielded same results. However, the PA-LAT CR dose of 114 mSv (104-127) for the pediatric phantom was not far from the 150 mSv for 4-to 7-year olds, reported by Gialousis et al. 21 Some of the explanation for the lowdose for the small-child CR is likely attributable to conventional imaging optimization. Furthermore, we used a reduced-dose scoliosis protocol with right lateral exposure. Radiation exposure of the lees radiation-sensitive right lateral side has been reported to reduce lateral effective dose by up to 28% for children. 22 For the adolescent phantom, we observed an effective dose reduction with EOS standard dose compared with CR, which is consistent with previous reports. 10, 11 Our EOS standard-dose results for both phantoms are consistent with most reports. [10] [11] [12] Organ doses to most organs were lower in PAL than in APL. Previous studies have documented that obtaining radiographs in the PA position decreases the amount of absorbed dose in most radiosensitive organs, and thus the effective dose. 12, 22, 23 By measuring organ dose in both APL and PAL, we were able to illustrate the dose divergence in the two positions for the EOS. The mean dose reduction in PAL versus APL was 21%. A 29% mean dose reduction to the breasts was observed in the adolescent phantom. This is consistent with findings of Luo et al, 11 when including lateral dose. The reported eight-fold reduction did not include lateral dose. 11 The EOS PAL position should be favored as a means of reducing the previously reported elevated risk of breast cancer. Historically, different methods have been applied for assessing organ dose and effective dose in the EOS scanner. Initially skin-entrance dose was described in comparisons of TLD measurements on skin surfaces with EOS and CR, and to calculate effective dose with the PCXMC method. 24 Clavel et al 12 used GATE organ volume simulation with PCXMC to compare with TLD dose measurements. Damet et al 10 reported organ dose and effective dose for the EOS standard protocol, based on measurements in anthropomorphic phantoms. The anthropomorphic phantoms provided us with a model closely mimicking the in vivo situation in terms of the anatomical placement of organs and tissue-equivalent materials. The setting allowed us to calculate patient organ doses and effective doses after direct exposure to dosimeters.
A limitation of the method used is the fact that measurements were based on 20 consecutive scans in each position and normalized to one scan, instead of making a number of individual scans and measurements. Damet et al 10 used only a fraction of available dosimeter placements (<25%) within the phantoms. Using only some of the predetermined dosimeter locations allows for considerable variations of dose measurements. For instance, four of 28 TLD locations were used in the liver for the adolescent phantom allowing for >20,000 possible combinations!. We chose to strengthen our study, by using all internal dosimeter locations. This allowed us to evaluate more precisely the mean absorbed dose within each organ. Furthermore, to address the uncertainties inherent in any studies within this area, we performed negative binomial regression analysis as described above. This model provided a more flexible framework for count data interpretation, than the Poisson regression, in the case of potential overdispersion, which was the case in this study.
Even with new low-dose imaging, we still have to keep focusing on ALARA, keeping the radiation dose as low as possible. The mean annual absorbed dose of ionizing radiation from medical causes is on the rise. Currently, the annual absorbed dose is estimated at 1.2 mSv. 25 So far, no lower threshold for the amount of ionizing radiation causing tissue damage, and potentially radiation-induced cancer has been established. 1 Still, we need to devote efforts to keeping the risk from radiation-induced cancer from full-spine examinations lower than previously reported levels;
3,26 and we need to continuously work towards minimizing the total radiation dose to which we expose our patients.
Key Points
This study presents first phantom measurements of organ dose, and effective dose calculations, with the EOS micro-dose protocol in full spine examinations. Radiation dose exposure from EOS micro-dose protocol was six to seven times less than the EOS standard-dose protocol. Effective dose with EOS micro-dose protocol was reduced 17-fold for the adolescent and five-fold for the pediatric phantom compared with CR. This study confirmed the fact that one EOS microdose full-spine examination corresponds to <1 week of natural background radiation. Our results also showed that the EOS standarddose protocol for full-spine examinations does not always offer lower radiation dose exposure than modern CR in small children.
